Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland
Stockholm, Sweden, 17 May, 2021 – Neobiomics AB and Ewopharma AG have entered an exclusive distribution agreement valid for the territory of Switzerland. The agreement includes marketing and sales of Neobiomics’ proprietary product ProPrems® and is in effect immediately. Neobiomics AB is a Sweden-based company… Read More »Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland